Fisher and Paykel Healthcare
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Fisher and Paykel Healthcare sits in the top decile of US sponsors by registered trial count (#626 of 15,742 sponsors by registered trial count).
Fisher and Paykel Healthcare: 25 sponsored US clinical trials, 1 recruiting.
Fisher and Paykel Healthcare sponsors 25 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 22 completed. The most-studied condition in this pipeline is Obstructive Sleep Apnea, with 5 trials.
Top-decile sponsor footprint
Fisher and Paykel Healthcare ranks in the top decile of sponsors by registered trial count (#626 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
22 of 24 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
25 total, page 1 of 1
Closed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the Hospital
NCT07222410
Evaluation of the F&P Caramel Nasal Mask, US, 2023
NCT06060717
Evaluation of the F&P Toffee Nasal Pillows Mask, US, 2022
NCT05573763
Evaluation of the Toffee Nasal and Toffee Nasal Pillows Mask in Home, USA, 2022
NCT05496062
The Evaluation of a New Nasal Mask for the Treatment of Obstructive Sleep Apnea
NCT04011826
The Evaluation of the Toffee Mask for the Treatment of Obstructive Sleep Apnea
NCT03726346
Evaluation of a Full-Face Mask for the Treatment of Obstructive Sleep Apnea (OSA)
NCT03329352
A Development Study to Evaluate a Full-Face Mask for the Treatment of Obstructive Sleep Apnea
NCT03272763
The Evaluation of the Toffee Nasal Pillows Mask for the Treatment of Obstructive Sleep Apnea
NCT03242148
The Evaluation of a Full Face Mask Seal for the Treatment of Obstructive Sleep Apnea
NCT03230877
The Evaluation of a Mask for the Treatment of Obstructive Sleep Apnea
NCT03142438
A Development Study to Evaluate a Nasal Mask for the Treatment of Obstructive Sleep Apnea
NCT03124069
CPAP In-home Assessment USA
NCT02809859
Nasal High Flow Therapy 30 Day Readmission Study
NCT02552732
Comparison Study Using APAP With and Without SensAwake in Patients With OSA and PTSD
NCT02549508
Positive Airway Pressure Program
NCT02331992
Adherence Risk Indicator Validation Study
NCT02230085
CAP Pilot Study for Obstructive Sleep Apnea (OSA)
NCT02309749
Comparison Study of the ICON™ CPAP Series With and Without SensAwake™
NCT01831258
Pilairo Lab Market Research
NCT01824979
Comparison Study of the ICON™ Auto Series With and Without SensAwake™ and ThermoSmart™ and Conventional Continuous Positive Airway Pressure in Obstructive Sleep Apnea Patients
NCT01517763
Patient Perception Questionnaire Validation
NCT02067000
Titration Pressures in Sleep Apnea Patients Using ThermoSmart® Versus Conventional Humidification
NCT00681083
Auto Continuous Positive Airway Pressure (CPAP) Based Energy Spectrum Analysis of Flow for Treatment of Obstructive Sleep Apnea Hypopnea Syndrome (OSAHS)
NCT00750165
ThermoSmart® Versus Conventional Humidification in Continuous Positive Airway Pressure (CPAP)
NCT00751335
Therapeutic Areas
What is open in the Fisher and Paykel Healthcare pipeline
1 recruiting of 25 indexed (4% open); 22 completed (88%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Obstructive Sleep Apnea (5 trials), 2 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Fisher and Paykel Healthcare: open-pipeline peers nationwide
Peers matched on 25 registered trials and 4% open enrollment, not the therapeutic-area sidebar.
Fisher and Paykel Healthcare sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 25 trials (± recruiting share)
- Arcus Biosciences · 25 trials · 12% recruiting
- Arcutis Biotherapeutics · 25 trials · 8% recruiting
- Ardelyx · 25 trials · 12% recruiting
- Drexel University College of Medicine · 25 trials · 0% recruiting
Sponsors near 4% open enrollment (± trial volume)
- Mesoblast · 4% recruiting · 25 trials
- ResMed · 4% recruiting · 25 trials
- Sangamo Therapeutics · 4% recruiting · 25 trials
- MedtronicNeuro · 4% recruiting · 51 trials
Related
What to do with this Fisher and Paykel Healthcare page
25 registered trials is a research-attention snapshot, not an endorsement of Fisher and Paykel Healthcare or any single study.
- 1 of Fisher and Paykel Healthcare's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obstructive Sleep Apnea is the condition Fisher and Paykel Healthcare studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obstructive Sleep Apnea trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Fisher and Paykel Healthcare pipeline card: 25 registered trials from official public datasets.Report a data error.